Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants

Eloxx Pharmaceuticals is offering 2,975,000 shares of common stock and pre-funded warrants to purchase up to 3,025,000 shares. The public offering price is $11.00 per share and $10.99 per pre-funded warrant, producing total gross proceeds of $65,969,750 before underwriting discounts. The underwriters expect to deliver the securities on or about June 10, 2026. The prospectus states the offering proceeds to Eloxx, before expenses, are $61,349,750. The offering assumes 461,314 shares outstanding as of May 31, 2026 and concurrent exercises of up to 600,000 shares from existing pre-funded warrants. Pro forma cash and cash equivalents after the offering are presented as $65,713,000.

https://www.stocktitan.net/sec-filings/ELOX/424b4-eloxx-pharmaceuticals-inc-prospectus-filed-pursuant-to-rule-424-3847651ef662.html